Mohammadreza Salehi to Middle Aged
This is a "connection" page, showing publications Mohammadreza Salehi has written about Middle Aged.
Connection Strength
0.050
-
Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern. Mycoses. 2020 Aug; 63(8):771-778.
Score: 0.014
-
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran. Mycoses. 2021 Oct; 64(10):1238-1252.
Score: 0.004
-
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res. 2021 Feb 11; 26(1):20.
Score: 0.004
-
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020 12; 56(6).
Score: 0.004
-
CT-scan findings of COVID-19 pneumonia based on the time elapsed from the beginning of symptoms to the CT imaging evaluation: a descriptive study in Iran. Rom J Intern Med. 2020 Dec 01; 58(4):242-250.
Score: 0.004
-
Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran. Arch Iran Med. 2020 11 01; 23(11):766-775.
Score: 0.004
-
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial. Int J Antimicrob Agents. 2020 Oct; 56(4):106143.
Score: 0.004
-
A Randomized Clinical Trial of the Efficacy and Safety of Interferon ß-1a in Treatment of Severe COVID-19. Antimicrob Agents Chemother. 2020 08 20; 64(9).
Score: 0.004
-
Maternal death due to COVID-19. Am J Obstet Gynecol. 2020 07; 223(1):109.e1-109.e16.
Score: 0.004
-
Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017. Infect Disord Drug Targets. 2020; 20(5):748-751.
Score: 0.003
-
Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial. Ear Nose Throat J. 2017 Feb; 96(2):E18-E22.
Score: 0.003